{
    "nct_id": "NCT02996110",
    "official_title": "A Phase 2, Real-time Assessment of Combination Therapies in Immuno-Oncology Study in Participants With Advanced Renal Cell Carcinoma (FRACTION-RCC)",
    "inclusion_criteria": "* Advanced Renal Cell Carcinoma\n* Must have at least 1 lesion with measurable disease\n* Life expectancy of at least 3 months\n* Karnofsky Performance Status (KPS) must be =>70%\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients/subjects with suspected or known central nervous system metastases unless adequately treated\n* Patients/subjects with autoimmune disease\n* Patients/subjects who need daily oxygen therapy\n\nOther protocol defined inclusion/exclusion criteria apply",
    "miscellaneous_criteria": ""
}